Developer docs
API playgroundTry for free, no card

Search company profiles

MySimplePetLab

Full company profile

uuid0002kqp

Namestring
MySimplePetLab
Legal namestring
MySimplePetLab Inc.
Company typeenum
Private
Founded yearint
2019
Descriptiontext

MySimplePetLab Inc. is a private, venture-backed pet health company founded in 2019 and headquartered in Centennial, Colorado (Delaware-incorporated), focused on at-home diagnostic testing for dogs and cats. Its core product is a portfolio of at-home pet health diagnostic kits that enable pet owners to perform routine health screening and wellness monitoring without a veterinary clinic visit. The kits are sold direct-to-consumer online, with stated plans to extend distribution into physical retail stores and to broaden the product line beyond the initial dog and cat offerings, alongside ambitions to build nationwide testing and data-sharing infrastructure.

The company operates a one-time-sale revenue model on individual diagnostic kits, targeting pet owners as its primary persona and positioning itself as improving pet healthcare accessibility and veterinary clinic efficiency. It has raised approximately $9.65 million+ across multiple SEC-registered exempt offerings between 2022 and 2024, most notably a $5 million Series A in November 2022 led by Mars Companion Fund / Mars Venture Fund (Mars Petcare-affiliated). The firm employs 11-50 people and has no disclosed named customers, enterprise contracts, or recurring subscription layer. Public information does not disclose pricing, gross margins, revenue, AI/ML capabilities, patents, or executive leadership detail, which materially limits visibility into unit economics and operating performance.

Short descriptiontext

MySimplePetLab is a private pet health startup that sells at-home diagnostic testing kits for dogs and cats via direct-to-consumer online channels, targeting US pet owners seeking convenient wellness screening without veterinary clinic visits.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDenver, United States
HQ citystring
Denver
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pet diagnostic testing, at-home pet care, veterinary diagnostics, pet wellness monitoring, animal health testing
Industry1 code
PRIMARYHLAMADAI
Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Medical Laboratories621511
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
Product category
Pet Health Diagnostics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pet Diagnostic Testing Kits
TypeOne Time License
Description

Sale of at-home diagnostic testing products for pets (dogs and cats) enabling health screening and wellness monitoring without veterinary clinic visits

vcaonline.com
Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

MySimplePetLab provides at-home pet health diagnostic testing kits for dogs and cats, enabling pet owners to conduct health screenings and wellness monitoring without visiting a veterinary clinic. The company supplies the tests, diagnostic technology, laboratory processing, operations, and results to deliver simple pet care from home or in-clinic. It sells its own branded diagnostic kit products directly to pet owners and intends to expand into retail distribution.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Improved pet healthcare accessibility through at-home testing
Product overview1 text field

MySimplePetLab offers a portfolio of at-home pet health diagnostic testing products, including testing kits designed for dogs and cats. The company operates as a pet health startup focused on improving pet wellness accessibility through home-based testing solutions that enable pet owners to conduct health assessments without requiring immediate veterinary visits. The company has raised Series A funding to expand its testing services and technology infrastructure.

Product and service2 records
1At-Home Pet Health Tests
CategoryPet diagnostic testing kits
Description

At-home diagnostic testing kits for dogs and cats that allow pet owners to conduct health tests without visiting a veterinarian, with plans to enhance nationwide testing and data sharing capabilities.

2Home Testing Kits (Retail Line)
CategoryPet diagnostic testing kits
Description

Retail-packaged home testing kits for dogs and cats designed to improve pet healthcare accessibility and veterinary clinic efficiency, with planned in-store distribution and product line expansion.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global animal health leader with diagnostics, devices, and pharmaceuticals across companion and livestock; relevant incumbent across the pet diagnostics value chain, now including Basepaws.

TypeEmerging player
Description

Telehealth and at-home care platform for pets that incorporates remote symptom triage and may integrate or compete with at-home diagnostic testing flows.

TypeEmerging player
Description

Developer of liquid biopsy (OncoK9) for cancer detection in dogs; overlaps with MySimplePetLab's diagnostic focus on dogs but operates in a higher-acuity, vet-channel-delivered niche.

TypeDirect peer
Description

Pet genetic testing and wellness plans, particularly in Australia/US; comparable DTC genetic and health screening offerings targeted at pet owners and breeders.

TypeDirect peer
Description

At-home cat and dog genetic and oral health test kits, now owned by Zoetis; competes head-to-head with MySimplePetLab in the DTC pet health testing category.

TypeEmerging player
Description

Online veterinary telehealth marketplace; an adjacent digital pet care company reshaping access to veterinary advice alongside at-home diagnostic offerings.

TypeDirect peer
Description

Direct-to-consumer dog genetic and health testing brand; competes for the same dog-owner attention with at-home saliva/swab kits and online results portal.

TypeDirect peer
Description

Long-established at-home pet DNA and health screening brand owned by Mars Petcare; the most direct analogue and benchmark for MySimplePetLab's at-home testing model.

TypeBroad incumbent
Description

Dominant veterinary diagnostics company providing in-clinic analyzers and reference lab services; sets the standard for pet diagnostic accuracy that MySimplePetLab's at-home kits must meet.

TypeBroad incumbent
Description

Mars Petcare-owned veterinary reference laboratory network; the strategic relationship between Antech's parent (Mars) and MySimplePetLab makes this both a peer and a channel partner.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MySimplePetLab

Pet Health Diagnosticsmysimplepetlab.com

MySimplePetLab is a private pet health startup that sells at-home diagnostic testing kits for dogs and cats via direct-to-consumer online channels, targeting US pet owners seeking convenient wellness screening without veterinary clinic visits.

What MySimplePetLab does

MySimplePetLab Inc. is a private, venture-backed pet health company founded in 2019 and headquartered in Centennial, Colorado (Delaware-incorporated), focused on at-home diagnostic testing for dogs and cats. Its core product is a portfolio of at-home pet health diagnostic kits that enable pet owners to perform routine health screening and wellness monitoring without a veterinary clinic visit. The kits are sold direct-to-consumer online, with stated plans to extend distribution into physical retail stores and to broaden the product line beyond the initial dog and cat offerings, alongside ambitions to build nationwide testing and data-sharing infrastructure.

The company operates a one-time-sale revenue model on individual diagnostic kits, targeting pet owners as its primary persona and positioning itself as improving pet healthcare accessibility and veterinary clinic efficiency. It has raised approximately $9.65 million+ across multiple SEC-registered exempt offerings between 2022 and 2024, most notably a $5 million Series A in November 2022 led by Mars Companion Fund / Mars Venture Fund (Mars Petcare-affiliated). The firm employs 11-50 people and has no disclosed named customers, enterprise contracts, or recurring subscription layer. Public information does not disclose pricing, gross margins, revenue, AI/ML capabilities, patents, or executive leadership detail, which materially limits visibility into unit economics and operating performance.

MySimplePetLab firmographics

Firmographics
Name
MySimplePetLab
Legal name
MySimplePetLab Inc.
Website
https://mysimplepetlab.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
MySimplePetLab is a private pet health startup that sells at-home diagnostic testing kits for dogs and cats via direct-to-consumer online channels, targeting US pet owners seeking convenient wellness screening without veterinary clinic visits.
Ownership category
akta.pro rank

MySimplePetLab industry classification

Industry
Product category
Pet Health Diagnostics
NAICS
Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAMADAI
Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)

Keywords

  • Pet diagnostic testing
  • At-home pet care
  • Veterinary diagnostics
  • Pet wellness monitoring
  • Animal health testing

Where MySimplePetLab is headquartered

Location

Headquarters

HQ city
Denver
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MySimplePetLab business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Pet Diagnostic Testing Kits: Sale of at-home diagnostic testing products for pets (dogs and cats) enabling health screening and wellness monitoring without veterinary clinic visits

Go-to-market motion1 record

Distribution channels2 records

MySimplePetLab product offering

Product offering

Core offering

MySimplePetLab provides at-home pet health diagnostic testing kits for dogs and cats, enabling pet owners to conduct health screenings and wellness monitoring without visiting a veterinary clinic. The company supplies the tests, diagnostic technology, laboratory processing, operations, and results to deliver simple pet care from home or in-clinic. It sells its own branded diagnostic kit products directly to pet owners and intends to expand into retail distribution.

Product overview

MySimplePetLab offers a portfolio of at-home pet health diagnostic testing products, including testing kits designed for dogs and cats. The company operates as a pet health startup focused on improving pet wellness accessibility through home-based testing solutions that enable pet owners to conduct health assessments without requiring immediate veterinary visits. The company has raised Series A funding to expand its testing services and technology infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

  • At-Home Pet Health Tests At-home diagnostic testing kits for dogs and cats that allow pet owners to conduct health tests without visiting a veterinarian, with plans to enhance nationwide testing and data sharing capabilities.
  • Home Testing Kits (Retail Line) Retail-packaged home testing kits for dogs and cats designed to improve pet healthcare accessibility and veterinary clinic efficiency, with planned in-store distribution and product line expansion.

Quantifiable outcome

  • Improved pet healthcare accessibility through at-home testing

Companies that use MySimplePetLab

Customer profile

Segments1 record

Ideal customer profiles2 records

MySimplePetLab technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

MySimplePetLab partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

MySimplePetLab competitors and assessment

Company assessment

Broad incumbents

  • Zoetis: Global animal health leader with diagnostics, devices, and pharmaceuticals across companion and livestock; relevant incumbent across the pet diagnostics value chain, now including Basepaws.
  • IDEXX Laboratories: Dominant veterinary diagnostics company providing in-clinic analyzers and reference lab services; sets the standard for pet diagnostic accuracy that MySimplePetLab's at-home kits must meet.
  • Antech Diagnostics: Mars Petcare-owned veterinary reference laboratory network; the strategic relationship between Antech's parent (Mars) and MySimplePetLab makes this both a peer and a channel partner.

Emerging players

  • Petriage: Telehealth and at-home care platform for pets that incorporates remote symptom triage and may integrate or compete with at-home diagnostic testing flows.
  • PetDx: Developer of liquid biopsy (OncoK9) for cancer detection in dogs; overlaps with MySimplePetLab's diagnostic focus on dogs but operates in a higher-acuity, vet-channel-delivered niche.
  • Vetster: Online veterinary telehealth marketplace; an adjacent digital pet care company reshaping access to veterinary advice alongside at-home diagnostic offerings.

Direct peers

  • Orivet: Pet genetic testing and wellness plans, particularly in Australia/US; comparable DTC genetic and health screening offerings targeted at pet owners and breeders.
  • Basepaws (Zoetis): At-home cat and dog genetic and oral health test kits, now owned by Zoetis; competes head-to-head with MySimplePetLab in the DTC pet health testing category.
  • Embark Veterinary: Direct-to-consumer dog genetic and health testing brand; competes for the same dog-owner attention with at-home saliva/swab kits and online results portal.
  • Wisdom Panel: Long-established at-home pet DNA and health screening brand owned by Mars Petcare; the most direct analogue and benchmark for MySimplePetLab's at-home testing model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

MySimplePetLab social profiles

Digital presence

MySimplePetLab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MySimplePetLab leadership team

Management profile

Number of profiles

MySimplePetLab funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MySimplePetLab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MySimplePetLab

What does MySimplePetLab do?

MySimplePetLab provides at-home pet health diagnostic testing kits for dogs and cats, enabling pet owners to conduct health screenings and wellness monitoring without visiting a veterinary clinic. The company supplies the tests, diagnostic technology, laboratory processing, operations, and results to deliver simple pet care from home or in-clinic. It sells its own branded diagnostic kit products directly to pet owners and intends to expand into retail distribution.

Is MySimplePetLab a public or private company?

MySimplePetLab is a private company. It is classified as venture growth investor backed and is currently operating.

When was MySimplePetLab founded?

MySimplePetLab was founded in 2019. It employs 1 to 10 people.

Where is MySimplePetLab based?

MySimplePetLab is headquartered in Denver, United States, in the North America region.

How does MySimplePetLab make money?

One revenue line is on record: pet Diagnostic Testing Kits.

Who are MySimplePetLab's main competitors?

Broad incumbents on record are Zoetis, IDEXX Laboratories and Antech Diagnostics. Emerging players are Petriage, PetDx and Vetster. Direct peers are Orivet, Basepaws (Zoetis), Embark Veterinary and Wisdom Panel.

Does MySimplePetLab have an API?

No public API is recorded for MySimplePetLab.

What industry is MySimplePetLab in?

MySimplePetLab's product category is Pet Health Diagnostics. Its primary akta.pro industry code is HLAMADAI, Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers). Its NAICS code is 62151 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American City Business JournalsMinneapolis pet-health startup MySimplePetLab lands deals with Target, PetSmartMySimplePetLab, a Minneapolis-based pet-health startup, secured deals with Target and PetSmart to offer in-home testing kits. The company will have two new kits on Target shelves this month, and its Denver lab analyzes samples within two days. The company has raised just under $10 million and plans to expand with retailers.SecSEC FORM DMySimplePetLab Inc. filed a Form D with the U.S. Securities and Exchange Commission to report an exempt offering of securities under Regulation D, specifically Rule 504(b)(1) and Rule 506(b). The filing indicates a total offering amount of $3,000,010 USD, with equity securities offered and three investors identified as of the first sale on November 13, 2023. The company is based in Centennial, Colorado, and the offering was signed by attorney Dan Buechler.PR NewswireBetter Pet Care Is Here: MySimplePetLab's First Aid Care Dog Kit is Now Available in Target Stores Nationwide and Offering Free Virtual Veterinary Advice with PurchaseMySimplePetLab has expanded its distribution by making its First Aid Care Dog Kit available in Target stores nationwide, a move following an earlier online launch this summer. The kit includes free virtual veterinary advice and is part of the company's strategy to provide accessible pet wellness solutions through its partnership with Target.PR NewswireTHE FUTURE OF PET CARE IS NOW: MYSIMPLEPETLAB LAUNCHES FIRST OF ITS KIND CARE KITS, REIMAGINING PET WELLNESS, MADE SIMPLE.MySimplePetLab launched targeted relief dog care kits for common pet concerns like digestive issues and ear infections. The kits retail for $39.99 and will roll out to over 500 Target locations in Fall 2023, with a Target.com launch in Summer 2023.Retail BrewPet trick: How a diagnostic lab for pets fashioned itself into a retail brandMySimplePetLab sells pet diagnostic test kits directly to consumers, with results emailed to owners and vets. The company is launching $40 care kits on Target's website within 30 days, with plans for cat kits. It cites a veterinarian shortage and rising pet ownership as drivers.SecSEC FORM DMySimplePetLab Inc. filed a Form D with the Securities and Exchange Commission to report an exempt offering of securities, claiming exemptions under Rule 504(b)(1) and Rule 506. The filing indicates a total offering amount of $6,000,000 USD with a minimum investment of $50,161, and notes that three investors have already participated in the offering.FinSMEsMySimplePetLab Raises Series A FundingMySimplePetLab, a Minneapolis-based pet diagnostic test provider, raised an undisclosed Series A led by Mars Companion Fund. The company will use the funds to grow its team, expand consumer lab testing, and scale technology to automate pet care friction points.Venture Capital Access OnlineMYSIMPLEPETLAB RAISES SERIES A FUNDING LED BY MARS COMPANION FUNDMySimplePetLab announced a Series A funding round led by Mars Companion Fund to expand its team and scale its at-home pet diagnostic testing technology. The investment aims to automate pet care processes and increase access to veterinary diagnostics for the projected 75 million pets expected to lack easy care access by 2030.ForbesPet Diagnostics Startup Raises $5 Million In Financing, Led By Mars Venture FundMySimplePetLab, a pet diagnostics startup, has secured $5 million in Series A funding led by the Mars Inc. Companion Fund to expand its home testing kits for dogs and cats. The investment aims to support the company's mission of providing accessible veterinary testing that alleviates workflow issues and staff shortages at vet clinics while offering proactive health monitoring for pet owners.